Former FDA Official Tim Coté Joins Emmaus Medical as Regulatory Advisor

May 09, 2013

TORRANCE, Calif., May 9, 2013 –Timothy Coté, M.D., MPH, former director of the Office of Orphan Product Development of the U.S. Food and Drug Administration, has joined Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, in an advisory capacity, the company announced today. Dr. Coté will advise Emmaus on the regulatory pathway for the company’s sickle cell disease treatment.

Documents